Answers are grounded in this paper and cite their sources.
Acute lung injury (ALI) is a severe inflammatory disorder with limited effective targeted therapies. Macrophage‐associated ferroptotic stress contributes significantly to uncontrolled pulmonary inflammation, making it a promising therapeutic target for ALI treatment. Here, we report biomimetic macrophage membrane‐coated hesperetin (HST)‐magnesium (Mg 2 + ) nanoparticles (MM@HST‐Mg NPs) that integrate inflammation‐targeted delivery with ferroptosis modulation for the treatment of lipopolysaccharide (LPS)‐induced ALI. The macrophage membrane coating enabled MM@HST‐Mg NPs preferentially accumulate in inflamed lungs and be predominantly taken up by pulmonary macrophages. Compared with free HST or HST‐Mg, MM@HST‐Mg NPs exhibited superior therapeutic efficacy. They alleviated macrophage‐associated ferroptotic stress by scavenging reactive oxygen species (ROS), reducing intracellular Fe 2 + accumulation, suppressing lipid peroxidation, and activating the Nrf2/HO‐1/GPX4 antioxidant pathway. Surface plasmon resonance (SPR) demonstrated that Mg 2 + coordination enhanced the interaction between HST and Nrf2. Furthermore, Nrf2 knockdown and pharmacological inhibition confirmed that the anti‐ferroptotic and macrophage‐reprogramming effects of MM@HST‐Mg NPs were largely dependent on Nrf2 signaling. These coordinated effects promoted macrophage polarization toward an anti‐inflammatory phenotype, attenuated pulmonary inflammation, and effectively protected mice against LPS‐induced ALI following early intervention. Overall, this study establishes a biomimetic macrophage‐targeted nanoplatform for ferroptosis modulation and provides a rational strategy for developing immunoregulatory nanomedicines for acute inflammatory lung injury.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: